![](https://cdn.sanity.io/images/0vv8moc6/oncnurse/3319f0722c506002ab1f5c8e822bb68c76d1968e-1920x1080.png?fit=crop&auto=format)
Tailoring Second-Line Treatments for HR-Positive, HER2-Negative Metastatic Breast Cancer
The dynamic landscape of second-line treatments for patients with HR-positive, HER2-negative metastatic breast cancer presents both opportunities and challenges for oncology nurses and APPs, highlighting the importance of staying informed about the latest …